HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

ITH15004

Also Known As:

2-(6-chloro-9H-purin-9-yl)-1-(2,4-dichlorophenyl)ethan-1-one

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Purines: 651
      - ITH15004: 1

Experts

1.	Alarcón-Vila, Cristina: 1 article (01/2022)
2.	Alves, Mariana: 1 article (01/2022)
3.	Beamer, Edward: 1 article (01/2022)
4.	Calzaferri, Francesco: 1 article (01/2022)
5.	Conte, Giorgia: 1 article (01/2022)
6.	Dinkel, Klaus: 1 article (01/2022)
7.	Engel, Tobias: 1 article (01/2022)
8.	García, Antonio G: 1 article (01/2022)
9.	Hamacher, Michael: 1 article (01/2022)
10.	Henshall, David C: 1 article (01/2022)

Related Diseases

1.	Status Epilepticus (Complex Partial Status Epilepticus) 01/01/2022 - "Pretreatment of wild-type mice with LPS increased P2X7 receptor levels in the brain and reduced responsiveness to anticonvulsants during status epilepticus, which was overcome by either genetic deletion of P2X7 receptors or treatment with the P2X7 receptor antagonists, AFC-5128 or ITH15004. "

Related Drugs and Biologics

1.	Purinergic P2X7 Receptors
2.	Anticonvulsants (Antiepileptic Drugs)